What do we need most, to keep genomics moving?
Genomic data can have a significant effect on other areas of society. Insurance premiums, familial impact, identification. As we enter the genomic era, policy will need to reflect these new considerations.
As new genomic information becomes available, is the clinic duty bound to inform patients who might be affected?